The predictive power of depression screening procedures for veterans with coronary artery disease by Shankman, Stewart A et al.
© 2012 Shankman et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Vascular Health and Risk Management 2012:8 233–238
Vascular Health and Risk Management
The predictive power of depression screening 







1Department of Psychiatry and 
Psychology, University of Illinois, 
2Department of Cardiology, Jesse 
Brown VA Medical Center, Chicago, 
IL, USA
*These authors contributed equally  
to this work
Correspondence: Mladen Vidovich 
Section of Cardiology, Jesse Brown VA 
Medical Center, Assistant Professor of 
Medicine, University of Illinois at Chicago, 
840 S Wood St, MC 715, Chicago,  
IL 60612, USA 
Tel +1 312 996 6730 
Fax +1 312 413 2948 
Email miv@uic.edu
Abstract: Depression leads to a worse outcome for patients with coronary artery disease 
(CAD). Thus, accurately identifying depression in CAD patients is imperative. In many   veterans 
affairs (VA) hospitals, patients are screened for depression once a year using the patient health 
  questionnaire (PHQ-9). Although the PHQ-9 is generally considered a specific and sensitive 
measure of depression, there is reason to believe that these screening procedures may miss a 
large number of cases of depression within CAD patients and cardiology patients more   generally. 
The goal of this study was to provide data as to the predictive power of this depression screen-
ing procedure by (a) comparing the prevalence rate of depression identified by the PHQ-9 to 
known prevalence rates and (b) examining whether patients identified as “depressed” also 
had conditions that consistently co-occur with depression (eg, post-traumatic stress disorder 
[PTSD], other medical issues). Participants were 813 consecutive patients who received an 
angiogram in the cardiac catheterization laboratory at a large VA Medical Center. Prevalence 
of depression was 6.9% in the overall sample and less than 6% when the sample was restricted 
to CAD patients with significant stenosis. Depression was significantly associated with PTSD, 
smoking, and alcohol problems. However, depression was not associated with other medical 
problems such as diabetes, renal failure, peripheral vascular disease, or anemia. In conclusion, 
the low prevalence rate of depression and lack of associations with comorbid medical problems 
may suggest that the VA’s depression screening procedures have low sensitivity for identifying 
depression in CAD patients. It is recommended that clinicians treating CAD regularly screen 
for depression and do not rely on archival depression screens.
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Introduction
Studies have consistently demonstrated that the prognosis, outcome, and treatment 
adherence for coronary artery disease (CAD) patients with comorbid major depressive 
disorder (MDD) is worse than in those without MDD.1–4 Thus, accurate identification 
of MDD in CAD patients is critical.5,6 Many hospitals (including most Veteran’s Affairs 
[VA] hospitals) screen for depression annually using the Patient Health Questionnaire 
(PHQ-9), a questionnaire which assesses for depressive symptoms over the   previous 
two weeks.7–9 While the PHQ-9 has demonstrated adequate validity at correctly 
identifying patients with MDD, screening for depression annually may miss a large 
number of cases (ie, false negatives) as the episodes of MDD may not correspond with 
the timing of the screening.
The goal of this study is therefore to provide data regarding the predictive 
power of annual depression screening in CAD patients and patients who   underwent 
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  catheterization procedures more generally. First, we   examined 
whether the prevalence rate is consistent with the known 
prevalence rate of depression. Second, given that numerous 
studies have shown that depression is highly comorbid with 
post-traumatic stress disorder (PTSD),10,11 substance use 
disorders,11,12 and several chronic medical diseases and CAD 
risk factors (diabetes,13 renal failure,14 peripheral vascular 
disease (PVD),15 anemia,16 and   hypertension),17 we examined 
whether individuals with MDD (as assessed by the PHQ-9) 




Participants included all consecutive patients (N = 1087) 
from June 1, 2008 through June 1, 2010 who underwent 
cardiac catheterization at the Jesse Brown VA Medical 
Center   (Chicago, IL). Indications for cardiac catheter-
ization   followed standard practices in the United States. 
  Specifically, patients were referred for coronary angiog-
raphy after they were evaluated by a cardiologist and the 
procedure was indicated for them based on their clinical 
presentation and results of diagnostic tests such as electro-
cardiography, echocardiography, stress testing and Holter 
monitoring. Indications for coronary angiography included 
acute myocardial infarction, hemodynamic instability 
with or without cardiogenic shock, severe left ventricular 
  dysfunction or overt heart failure, recurrent or persistent 
rest angina (despite intensive medical therapy),   mechanical 
complications (such as acute mitral regurgitation or 
  ventricular septal defect), sustained ventricular tachycardia, 
inconclusive or conflicting results after noninvasive stress 
testing, patient’s ability to undergo noninvasive testing 
(disability, illness, or morbid obesity), or reevaluation of 
performed procedures (main stem percutaneous coronary 
intervention [PCI], high stenosis risk).
The inclusion/exclusion criteria were very broad. Given 
the low prevalence of women in this sample (N = 28; 
a   number which is consistent with the population of veterans 
in this age range), the sample was restricted to male veterans. 
An additional 246 veterans were excluded because they did not 
complete a patient health questionnaire (PHQ-9) within a year 
of the visit to the catheterization laboratory. Thus, excluding 
these participants yielded a final N = 813. This investigation 
was approved by the institutional review boards (IRB) at 
the Jessie Brown VA Medical Center and the   University of 
Illinois at Chicago and participants gave informed consent 
to have their medical records used for this research.
Measures
Medical variables
All coronary angiography reports were reviewed and the 
maximum percentage of stenosis was recorded for each 
patient. Revascularization procedures – coronary angio-
plasty (PCI), referral for coronary artery bypass surgery 
(CABG) – were recorded as well.
Depression assessment (PHQ-9)
The PHQ-9 is a nine item self-report questionnaire in which 
respondents rate the presence of the 9 core symptoms of a 
major depressive episode over the preceding two weeks. 
Each question is scored on a 4-point score where: 0 = not 
at all, 1 = several days, 2 = more than half the days, and 
3 = nearly every day. Although the PHQ-9 has been used as 
continuous measure of depression, in most medical   settings, 
the general convention is to determine cases of MDD with a 
cutoff of $10.8,9,18 Additionally, the PHQ-9 has been shown 
to be highly correlated with other validated measures of 
depression (eg, r = 0.73 with the Beck depression inven-
tory [BDI]).19
Other psychiatric and substance  
use variables
PTSD
The primary care-PTSD screen20 (PC-PTSD) is a 4-item 
self-report measure used to identify individuals with PTSD 
or trauma-related problems. The PC-PTSD asks patients to 
recall a traumatic event and indicate whether or not, over the 
past month, they experienced any of four symptoms related 
to the four core factors of PTSD.21 Presence of at least three 
symptoms identifies veterans with PTSD with strong sensi-
tivity (0.85) and specificity (0.82).20,22
Alcohol use disorders
The alcohol use disorders identification test23 (AUDIT-C) is a 
3-item self-report measure used to identify individuals with 
alcohol abuse or dependence. Scores range from 0–12 and a 
cutoff ≥ 4 identifies male veterans who drink heavily and/or 
have active alcohol abuse or dependence with a sensitivity 
of (0.86) and a sensitivity of (0.72).23,24
Of note is that the above cutoffs for the PC-PTSD and 
AUDIT are the ones adopted by the VA25,26 for determining 
referral or follow-up treatment for PTSD and alcohol prob-
lems, respectively. From patient’s medical records, we also 
recorded whether they reported smoking on a regular basis.
The PHQ-9, PTSD, and AUDIT-C screens are given 
annually to patients at most VA hospitals and the most recent 




Shankman et alVascular Health and Risk Management 2012:8
assessment prior to the patients’ cardiac catheterization was 
selected for analysis.
Data analysis
All analyses were performed using SPSS (v 16.0; SPSS Inc, 
Chicago, IL). T-tests and chi-squared tests were used for 
group comparisons on demographics. Logistic regressions 
(adjusted for covariates) were used to examine the associa-
tion between depression status and the psychiatric, substance 
and medical issues.
Results
Descriptive statistics and angiography
The sample had a mean age of 64.6 ± 10.8 years, body 
mass index (BMI) of 29.6 ± 6.4, and was ethnically diverse, 
although the majority of the sample was African-American: 
63.1% African-American, 32.8% White, 3.2% Hispanic and 
0.9% other ethnicity.
Normal coronaries were present in 24.1% of patients, 
19.5% had between 1 and 50% stenosis, 7.6% had between 
51% and 70% stenosis, 24.5% had between 71% and 99% 
stenosis, and 24.3% had 100% stenosis in one of the major 
coronary arteries. PCI was performed in 24.7% of the sample 
and an additional 10.7% were referred for CABG. The other 
64.6% of the sample received standard medical management 
for CAD.
Prevalence of depression
Of the 813 veterans who underwent catheterization procedures, 
only 56 scored $10 suggesting a prevalence of 6.9%.
If the sample was restricted to veterans with more than 
50% stenosis (N = 454), the prevalence was 5.9%. If the 
sample was restricted to more than 70% stenosis (N = 393), 
the prevalence was 5.6%. Thus, the estimated prevalence rate 
of depression was largely consistent whether all patients were 
examined or just patients with significant stenosis.
Additionally, in the overall sample, 640 (78.7%) scored a 
0 on the PHQ-9 (slightly larger percentages were observed in 
veterans with significant stenosis). Given the highly skewed 
nature of depressive symptoms in the present sample, for 
all subsequent analyses, we compared those who scored 
0 to those who scored above 10 (thus, excluding those who 
endorsed a few symptoms of depression, but fell below the 
clinically significant range). Compared to those who endorsed 
zero symptoms, veterans in the clinical range on the PHQ-9 
were significantly younger (55.8 versus 65.8, P , 0.001; 
adjusted for significant Levene’s Test) and had higher BMI 
(31.9 versus 29.2; P , 0.01), with no ethnic differences. 
Age and BMI were therefore included as covariates in the 
analyses below.
In order to examine whether the results varied by whether 
patients had significant stenosis (ie, true CAD patients), 
analyses were also conducted in those with (a) greater 
than 50% stenosis, and (b) greater than 70% stenosis. It 
is   noteworthy that depression was not related to degree of 
stenosis (r = −0.05, ns).
Association between depression 
and substance and psychiatric problems
The top of Table 1 presents results examining the 
co-occurrence of depression and several substance and 
psychiatric problems. After adjusting for age and BMI, 
smoking, alcohol, and PTSD were all significantly related 
to depression status on the PHQ-9 in the overall sample and 
in patients with significant stenosis.
Association with medical  
comorbidities/CAD risk factors
The bottom of Table 1 presents the results examining the 
  co-occurrence of depression and several medical issues and 
risk factors for CAD. Individuals with depression did not 
have a significantly greater likelihood of having   diabetes, 
renal failure, peripheral vascular disease, and anemia. 
  Individuals with depression had a marginally higher likeli-
hood of hypertension in the overall sample.
Discussion
This study examined the predictive power of the PHQ-9 in 
male veterans receiving cardiac catheterization. Given the 
importance of depression to the course and outcome of 
CAD,1,2 it is important that valid procedures for screening 
depression are in place. This is particularly true for veterans, 
a population for whom CAD is quite prevalent.10 Our study 
had several noteworthy findings.
In the overall sample, only 56 veterans scored in the clini-
cal range on the PHQ-9 suggesting a prevalence of 6.9%. 
Similar (and even somewhat lower) rates were observed if 
the analyses were restricted to true CAD patients with sig-
nificant stenosis (.50% or .70% blockage). Although the 
true prevalence of MDD in veterans with CAD is unknown, 
this number is considerably lower than what the literature 
would suggest. Studies in CAD patients suggest that the 
prevalence of MDD in patients with CAD in the general 
population is approximately 20%–23%.27,28 Additionally, 
one would   predict that this number would likely be higher in 
veterans given the increased rates of depression in veterans 
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compared to the general population.29 There are several 
possible explanations for this low prevalence rate.
First, it is possible that the PHQ-9 is uniformly invalid 
at assessing depression in veteran males with CAD. This 
conclusion, however, would be inconsistent with the overall 
strong predictive power exhibited by the PHQ-9 in other 
populations (including veterans).8,9 Additionally, this con-
clusion would be inconsistent with the fact that depression 
was significantly associated with comorbid mental health 
conditions. Numerous studies have shown that depression 
frequently co-occurs with PTSD, alcohol use disorders, and 
smoking problems.10–12 Thus, the fact that depression was 
associated with the mental health conditions in the present 
study suggests that PHQ-9 appeared to largely identify valid 
cases of depression.
An alternative and more likely reason for the low preva-
lence rate is that the PHQ-9 likely identified individuals 
with MDD (ie, low number of “false positives”) but the 
PHQ-9 likely missed a large number of cases as well (ie, 
large number of “false negatives.”). In other words, the 
PHQ-9 may have exhibited low sensitivity. Interestingly, 
our results were consistent with the Heart and Soul study, 
which found that the PHQ-9 may have strong specificity in 
CAD patients, but inadequate sensitivity in this   population.27 
This conclusion is also supported by the present finding that 
depression was not significantly associated with any of 
the medical issues/CAD risk factors or degree of stenosis, 
despite a large literature suggesting that depression should 
be correlated with these variables. Lastly, a high number 
of “false negatives” is also consistent with the fact that 
a surprisingly high 78.7% of CAD veterans denied any 
symptoms of depression.
Thus, the VA’s procedures for screening depression may 
not be adequately identifying all CAD patients who have 
depression. This is likely to be particularly problematic for 
African-American veterans (who compromised the largest 
percentage of our sample), a group who are not only at higher 
risk for CAD,30 but who are also less likely to seek mental 
health services on their own.31,32
A concern with the VA’s screening of depression may 
not be the screening instrument (PHQ-9), but rather the 
procedures under which it is administered. In most VA 
hospitals, the computerized personal record system flags 
patients who have not been administered the PHQ-9 within 
the last year and then reminds clinicians (typically primary 
care physicians) to administer it. Thus, depressive episodes 
that occurred closer in time to cardiac catheterization may 
be missed.
Additionally, the PHQ-9 is often administered by simply 
handing the patient the questionnaire and asking them to com-
plete it. The validity of a self-report questionnaire assumes 
that individuals can read and comprehend each question. 
A recent study showed that the PHQ-9 requires at least a ninth 
grade reading level.33 Hence, a subset of patients may have 
had difficulty reading and understanding the questions. We 
are currently investigating this issue by measuring the reading 
ability of patients who completed the PHQ-9 and examining 
whether this has an effect on depression prevalence.
It is important to assess for current depression when 
patients visit the cardiac catheterization laboratory because 
a depressive episode may have contributed to why patients 
are seeking cardiovascular care. Not only has depression 
been associated with both cardiac and non-cardiac chest 
pain,34,35 but there is a growing literature on the overlapping 
Table 1 Association between PHQ-9 assessed depression and conditions known to be associated with depression
% of total sample Association with PHQ-9 depression
Odds ratio (OR), 95% CI
Total sample Sample with .50% stenosis Sample with .70% stenosis
Psychiatric and substance use disorders
  PTSD 9.5% 4.01 (1.98–8.13)*** 2.91 (1.08–7.90)* 4.43 (1.53–12.82)**
  Smoking 25.7% 2.22 (1.22–4.04)** 4.82 (2.00–11.615)*** 5.17 (1.91–13.97)**
  Alcohol 10.7% 2.62 (1.29–5.30)** 2.86 (1.00–8.21)* 3.08 (0.96–9.93)+
Medical issue/CAD risk factor
  Diabetes 41.3% ns ns ns
  Renal failure 26.8% ns ns ns
  Peripheral vascular disease 17.7% ns ns ns
  Anemia 12.6% ns ns ns
  Hypertension 87.7% 4.01 (0.94–17.07)+ nsa nsa
Notes: All OR are adjusted for age and BMI. *P  0.05; **P  0.01; ***P  0.001; +P , 0.10; aFor patients with substantial stenosis, although non-significant, the confidence 
intervals for odds ratios could not be calculated for hypertension because every patient with depression (N = 27 in Veterans with .50% stenosis and N = 22 in veterans 
with .70% stenosis) had hypertension (and, conversely, no patient without hypertension had depression).
Abbreviations: BMI, body mass index; CI, confidence interval; CAD, coronary artery disease; ns, not-significant; OR, odds ratio; PTSD, post-traumatic stress disorder.
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pathophysiology between depression and cardiac disease.36 
For example, inflammatory cytokines, endothelial dysfunc-
tion and autonomic nervous system dysfunction have all 
been proposed to play a role in both depression and cardiac 
disease.36–41
Additionally, it is important to assess the urgency of a 
patient’s referral for cardiac catheterization, as severity of 
CAD would likely impact depression ratings. Unfortunately, 
in our archival database, we were unable to examine this 
question. However, it should be noted that the administration 
of the PHQ-9 was rarely the same day as the   catheterization. 
Currently in the VA system, the PHQ-9 is only given annually 
and its administration does not necessarily coincide with a 
cardiology visit (let alone an urgent cardiology visit). Thus, 
it is unlikely that ratings of depression were affected by the 
urgency of patients’ cardiac symptoms. Studies have also 
shown that among patients who have an urgent referral, iden-
tification of those with a psychological need is particularly 
predictive of outcome.42 This highlights the importance of 
assessing depression at the time of cardiac catheterization, as 
well as regular screening of depression during the treatment 
of CAD over time.
The conclusions of the study are tempered by several 
limitations. First, although our sample was representative of 
CAD patients (and veterans in general) who receive treat-
ment at the Jesse Brown VA, the sample was all male and 
predominantly African-American. Thus, our conclusions 
may not generalize to different populations. Second, the large 
percentage of patients with hypertension (87%) may have 
precluded us from finding a significant association between 
depression and this risk factor (although, it is noteworthy 
that this was the only medical issue/risk factor that even 
approached statistical significance). Third, MDD was not 
formally diagnosed (ie, with a diagnostic interview) in the 
patients. However, a formal assessment of MDD would have 
likely confirmed the low sensitivity of the PHQ-9 depression 
assessment procedures. Finally, given that we had to exclude 
women from the sample due to their low prevalence in the VA 
population, the results may not generalize to CAD patients 
in general, but perhaps only to male CAD patients.
In summary, our study found that the depression screen-
ing procedures employed in many VA medical centers may 
not be ideal as numerous cases of MDD are likely to be 
missed. Given the importance of depression as a predictor of 
prognosis and outcome in CAD, it is essential that clinicians 
do not solely rely on a patient’s archival depression screen 
and regularly screen for depression in cardiology clinics. 
Additionally, the problems with annual self-report   depression 
screening highlight the importance of future research to 
identify valid biomarkers for depression.
Disclosure
The authors report no conflicts of interest in this work.
References
  1.  Frasure-Smith N, Lesperance F, Talajic M. Depression   following 
myocardial infarction: Impact on 6-month survival. JAMA. 1993;   
270(15):1819–1825.
  2.  Carney RM, Freedland KE, Steinmeyer B, et al. Depression and five 
year survival following acute myocardial infarction: A prospective 
study. J Affect Disord. 2008;109(1–2):133–138.
  3.  Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk   factor 
for coronary artery disease: Evidence, mechanisms, and treatment. 
Psychosom Med. 2004;66(3):305–315.
  4.  Rugulies R. Depression as a predictor for coronary heart disease:   
A review and meta-analysis. Am J Prev Med. 2002;23(1):51–61.
  5.  Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and 
coronary heart disease: Recommendations for screening, referral, and 
treatment: A science advisory from the American Heart Association 
prevention committee of the council on cardiovascular nursing, council 
on clinical cardiology, council on epidemiology and prevention, and 
interdisciplinary council on quality of care and outcomes research. Prog 
Cardiovasc Nurs. 2009;24(1):19–26.
  6.  US Preventive Services Task Force. Screening for depression in adults: 
US preventive Services Task Force recommendation statement. Ann 
Intern Med. 2009;151(11):784–792.
  7.  United States Department of Veteran Affairs. Clinical practice guide-
lines-management of major depressive disorder (MDD) 2009.   Available 
from: http://www.healthquality.va.gov/mdd/mdd_full09_c.pdf. 
Accessed March 8, 2012.
  8.  Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a 
brief depression severity measure. J Gen Intern Med. 2001;16(9): 
606–613.
  9.  Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression 
in medical settings with the Patient Health Questionnaire (PHQ): a diag-
nostic meta-analysis. J Gen Intern Med. 2007;22(11):1596–1602.
  10.  Hankin CS, Spiro A, Miller DR, Kazis L. Mental disorders and 
mental health treatment among US department of Veterans Affairs 
outpatients: The veterans’ health study. Am J Psychiatry. 1999;   
156(12):1924–1930.
  11.  David D, Woodward C, Esquenazi J, Mellman TA. Comparison of 
comorbid physical illnesses among veterans with PTSD and veterans 
with alcohol dependence. Psychiatr Serv. 2004;55(1):82–85.
  12.  Kessler RC, Berglund P, Demler O, et al. The epidemiology of major 
depressive disorder – results from the national comorbidity survey 
replication (NCS-R). JAMA. 2003;289(23):3095–3105.
  13.  Anderson RJ, Freeland KE, Clouse RE, Lustman PJ. The prevalence of 
comorbid depression in adults with diabetes: a meta-analysis. Diabetes 
Care. 2001;24(6):1069–1078.
  14.  Sumanathissa M, de Silva VA, Hanwella R. Prevalence of major depres-
sive episode among patients with pre-dialysis chronic kidney disease. 
Int J Psychiatry Med. 2011;41(1):47–56.
  15.  McDermott MM, Greenland P, Guralnik JM, et al. Depressive symptoms 
and lower extremity functioning in men and women with peripheral 
arterial disease. J Gen Intern Med. 2003;18(6):461–467.
  16.  Stewart RB, Blashfield R, Hale WE, Moore MT, May FE, Marks RG. 
Correlates of Beck Depression Inventory scores in an ambulatory elderly 
population: symptoms, diseases, laboratory values, and medications.   
J Fam Pract. 1991;32(5):497–502.
  17.  Fiedorowicz JG, He J, Merikangas KR. The association between mood 
and anxiety disorders with vascular diseases and risk factors in a nation-
ally representative sample. J Psychosom Res. 2011;70(2):145–154.




Depression screenings in veteransVascular Health and Risk Management
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/vascular-health-and-risk-management-journal
Vascular Health and Risk Management is an international, peer-
reviewed journal of therapeutics and risk management, focusing on 
concise rapid reporting of clinical studies on the processes involved 
in the maintenance of vascular health; the monitoring, prevention and 
treatment of vascular disease and its sequelae; and the involvement of 
metabolic disorders, particularly diabetes. This journal is indexed on 
PubMed Central and MedLine. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Vascular Health and Risk Management 2012:8
  18.  Zuithoff NPA, Vergouwe Y, King M, et al. The Patient Health 
  Questionnaire-9 for detection of major depressive disorder in primary 
care: Consequences of current thresholds in a cross-sectional study. 
BMC Fam Pract. 2010;11:98.
  19.  Martin A, Rief W, Klaiberg A, Braehler E. Validity of the Brief Patient 
Health Questionnaire Mood Scale (PHQ-9) in the general population. 
Gen Hosp Psychiatry. 2006;28(1):71–77.
  20.  Prins A, Ouimette P, Kimerling R, et al. The primary care PTSD screen 
(PC-PTSD): development and operating characteristics. Prim Care 
Psychiatry. 2003;9:9–14.
  21.  Asmundson GJG, Frombach I, McQuaid J, Pedrelli P, Lenox R, 
Stein MB. Dimensionality of posttraumatic stress symptoms: A confir-
matory factor analysis of DSM-IV symptom clusters and other symptom 
models. Behav Res Ther. 2000;38(2):203–214.
  22.  Freedy JR, Magruder KM, Mainous AG, Frueh BC, Geesey ME, 
Carnemolla M. Gender differences in traumatic event exposure 
and mental health among veteran primary care patients. Mil Med. 
2010;175(10):750–758.
  23.  Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. 
  Ambulatory Care Quality Improvement Project. The AUDIT alcohol 
consumption questions (AUDIT-C) – an effective brief screening test 
for problem drinking. Arch Intern Med. 1998;158(16):1789–1795.
  24.  Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D,   
Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary 
care. Alcohol Clin Exp Res. 2007;31(7):1208–1217.
  25.  United States Department of Veterans Affairs. Primary care PTSD 
screen (PC-PTSD); 2010.
  26.  United States Department of Veterans Affairs. Management of sub-
stance use disorders (SUD); 2010.
  27.  McManus D, Pipkin SS, Whooley MA. Screening for depression in 
patients with coronary heart disease (data from the heart and soul study). 
Am J Cardiol. 2005;96(8):1076–1081.
  28.  Musselman DL, Evans DL, Nemeroff CB. The relationship of depres-
sion to cardiovascular disease – epidemiology, biology, and treatment. 
Arch Gen Psychiatry. 1998;55(7):580–592.
  29.  Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. 
Combat duty in Iraq and Afghanistan, mental health problems, and 
barriers to care. N Engl J Med. 2004;351(1):13–22.
  30.  National Institutes of Health. Morbidity and Mortality 2009 Chart 
Book on Cardiovascular, Lung and Blood Diseases 2009. Available 
from: http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf. 
Accessed March 8, 2012.
  31.  Rosenheck R, Fontana A. Utilization of mental health services by minority 
veterans of the Vietnam era. J Nerv Ment Dis. 1994;182(12):685–691.
  32.  Schraufhagel T, Wagner A, Miranda J, Roy-Byrne P. Treating minority 
patients with depression and anxiety; what does the evidence tell us? 
Gen Hosp Psychiatry. 2006;28(1):27–36.
  33.  McHugh KR, Behar E. Readability of self-report measures of depression 
and anxiety. J Consult Clin Psych. 2009;77(6):1100–1112.
  34.  Eken C, Oktay C, Bacanli A, et al. Anxiety and depressive disorders 
in patients presenting with chest pain to the emergency department: 
A comparison between cardiac and non-cardiac origin. J Emerg Med. 
2010;39(2):144–150.
  35.  Srinivasan D, Yen JH, Joseph DJ, Friedman W. Cell type-specific 
  interleukin-1 beta signaling in the CNS. J Neurosci. 2004;24(29): 
6482–6488.
  36.  Celano CM, Huffman JC. Depression and cardiac disease A review. 
Cardiol Rev. 2011;19(3):130–142.
  37.  Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis 
in inflammatory heart sisease. Trends Cardiovasc Med. 2009;19(8): 
247–252.
  38.  Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 
1999;340(2):115–126.
  39.  Howren MB, Lamkin DM, Suls J. Associations of depression with 
C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 
2009;71(2):171–186.
  40.  Miller AH, Maletic V , Raison CL. Inflammation and its discontents: 
The role of cytokines in the pathophysiology of major depression. Biol 
Psychiatry. 2009;65(9):732–741.
  41.  Vaccarino V , Johnson BD, Sheps DS, et al. Depression, inflammation 
and incident cardiovascular disease in women with suspected coronary 
ischemia – the national heart, lung, and blood institute-sponsored WISE 
study. J Am Coll Cardiol. 2007;50(21):2044–2050.
  42.  Gruen W. Effects of brief psychotherapy during the hospitalization 
period on the recovery process in heart attacks. J Consult Clin Psychol. 
1975;43(2):223–232.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
238
Shankman et al